Soparkar Kishor Peter's most recent trade in Adverum Biotechnologies Inc was a trade of 45,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 45,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 40,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 25,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 25,500 | 25,500 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 23,092 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 23,092 | 23,092 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 16,384 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 16,384 | 16,384 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 15,999 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 15,999 | 15,999 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 13,999 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 13,999 | 13,999 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 13,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2025 | 4,074 | 0 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 4,074 | 4,074 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 15 May 2025 | 2,960 | 39,154 (0%) | 0% | 2 | 5,920 | Common Stock |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 78,750 | 78,750 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 13,125 | 42,114 (0%) | 0% | 0 | Common Stock | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 64,394 | 64,394 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Soparkar Kishor Peter | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 450,000 | 450,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2023 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 15 Mar 2023 | 13,360 | 265,891 (0%) | 0% | 0.8 | 10,442 | Common Stock |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | See Remarks section | Sale of securities on an exchange or to another person at price $ 1.07 per share. | 19 Sep 2022 | 13,305 | 273,251 (0%) | 0% | 1.1 | 14,232 | Common Stock |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | See Remarks section | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 230,924 | 230,924 | - | - | Performance Based Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | See Remarks section | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 163,847 | 163,847 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | See Remarks section | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 19 Apr 2022 | 21,750 | 280,556 (0%) | 0% | 1.1 | 24,795 | Common Stock |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | See Remarks section | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 19 Apr 2022 | 175 | 258,806 (0%) | 0% | 1.1 | 199 | Common Stock |
| Adverum Biotechnologies Inc | Kishor Peter Soparkar | See Remarks section | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 255,000 | 255,000 | - | - | Stock Option (Right to Buy) |